This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Venous Thromboembolism  • Blood/ Coagulation  • Review  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Grace S. Rozycki, MD, MBA

Arch Surg. 2009;144(1):76.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The recent surge in the development and use of antiplatelet agents has underscored their central role in the management of vascular disease. As the number of vascular interventional procedures continues to increase, it is anticipated that more research will be done to further refine antiplatelet agents and discover new medications as well as find new uses for them.

The information in this article is especially useful to surgeons as they are most likely to encounter a patient who is taking antiplatelet agents and is in need of an urgent or emergent surgical procedure. But, as practice boundaries continue to blur, surgeons as well as our colleagues in radiology, neurology, neurosurgery, orthopedics, emergency medicine, and other specialties will continue to prescribe antiplatelet medications and/or take care of patients whose medication regimen includes them. To that end, O’Riordan and colleagues have opened a door for surgeons to . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Antiplatelet Agents in the Perioperative Period
James M. O’Riordan, Ronan J. Margey, Gavin Blake, and P. Ronan O’Connell
Arch Surg. 2009;144(1):69-76.
ABSTRACT | FULL TEXT